Thailand Microbiome Sequencing Outsourcing Services Market Report Size Share Growth Drivers Trends Opportunities & Forecast 2025–2030

Thailand Microbiome Sequencing Outsourcing Services Market, valued at USD 140 million, grows due to demand in healthcare, agriculture, and personalized medicine advancements.

Region:Asia

Author(s):Geetanshi

Product Code:KRAE1601

Pages:85

Published On:March 2026

About the Report

Base Year 2024

Thailand Microbiome Sequencing Outsourcing Services Market Overview

  • The Thailand Microbiome Sequencing Outsourcing Services Market is valued at USD 140 million, based on a five-year historical analysis. This growth is primarily driven by the increasing prevalence of chronic diseases, rising awareness of personalized medicine, advancements in sequencing technologies, escalating interest in human microbiota studies, increased incidence of gastrointestinal disorders, concerns about antibiotic resistance, and expanded disease diagnostic applications. The demand for microbiome analysis in healthcare, agriculture, and environmental monitoring has significantly contributed to the market's expansion.
  • Key players in this market include Bangkok, Chiang Mai, and Nakhon Ratchasima. Bangkok, as the capital, is a hub for healthcare and research institutions, while Chiang Mai is known for its academic research facilities. Nakhon Ratchasima has been emerging due to its agricultural focus, driving demand for microbiome studies in agriculture and environmental applications.
  • The Medical Biotechnology Act, B.E. 2559 (2016) issued by the Ministry of Public Health governs microbiome research and development activities. This binding instrument requires licensing for biotechnology operations involving genetic sequencing, mandates compliance with biosafety standards for handling microbial samples, sets thresholds for laboratory containment levels based on risk categories, and establishes standards for data protection and ethical review in research collaborations.
Thailand Microbiome Sequencing Outsourcing Services Market Size

Thailand Microbiome Sequencing Outsourcing Services Market Segmentation

By Type:The market is segmented into various types of sequencing services, including Whole Genome Sequencing, Targeted Sequencing, Metagenomic Sequencing, RNA Sequencing, and Others. Whole Genome Sequencing is currently the leading sub-segment due to its comprehensive analysis capabilities, which are essential for understanding complex microbial communities. Targeted Sequencing is also gaining traction, particularly in clinical applications where specific pathogens need to be identified. The demand for these services is driven by advancements in technology and the increasing need for personalized medicine.

Thailand Microbiome Sequencing Outsourcing Services Market segmentation by Type.

By End-User:The market is categorized by end-users, including Academic Research Institutions, Pharmaceutical Companies, Clinical Laboratories, Biotechnology Firms, and Others. Academic Research Institutions dominate the market due to their focus on microbiome research and the need for advanced sequencing technologies. Pharmaceutical companies are also significant users, leveraging microbiome data for drug development and personalized medicine. The increasing collaboration between academia and industry is further driving the demand for sequencing services.

Thailand Microbiome Sequencing Outsourcing Services Market segmentation by End-User.

Thailand Microbiome Sequencing Outsourcing Services Market Competitive Landscape

The Thailand Microbiome Sequencing Outsourcing Services Market is characterized by a dynamic mix of regional and international players. Leading participants such as BGI Group, Illumina, Inc., Thermo Fisher Scientific, Novogene Co., Ltd., Macrogen, Inc., QIAGEN N.V., Genomatix Software GmbH, Zymo Research Corp., Oxford Nanopore Technologies, Roche Sequencing Solutions, Agilent Technologies, Bio-Rad Laboratories, PerkinElmer, Inc., Ginkgo BioWorks, Genomatix Software GmbH contribute to innovation, geographic expansion, and service delivery in this space.

BGI Group

1999

Shenzhen, China

Illumina, Inc.

1998

San Diego, USA

Thermo Fisher Scientific

1956

Waltham, USA

Novogene Co., Ltd.

2011

Beijing, China

Macrogen, Inc.

1997

Seoul, South Korea

Company

Establishment Year

Headquarters

Group Size (Large, Medium, or Small as per industry convention)

Revenue Growth Rate

Customer Acquisition Cost

Market Penetration Rate

Customer Retention Rate

Pricing Strategy

Thailand Microbiome Sequencing Outsourcing Services Market Industry Analysis

Growth Drivers

  • Increasing Demand for Personalized Medicine:The Thai healthcare market is witnessing a significant shift towards personalized medicine, driven by a growing population of over 70 million. In future, the personalized medicine market in Thailand is projected to reach approximately THB 18 billion, reflecting a 10% annual growth rate. This trend is fueled by advancements in genomics and microbiome research, which enable tailored treatment plans based on individual microbiome profiles, enhancing patient outcomes and driving demand for sequencing services.
  • Rising Prevalence of Chronic Diseases:Chronic diseases such as diabetes and cardiovascular conditions are on the rise in Thailand, with over 12 million diagnosed cases reported in future. The World Health Organization indicates that these diseases account for 73% of total deaths in the country. This alarming trend is prompting healthcare providers to seek innovative solutions, including microbiome sequencing, to better understand disease mechanisms and develop effective interventions, thereby boosting the outsourcing services market.
  • Advancements in Sequencing Technologies:The microbiome sequencing landscape in Thailand is rapidly evolving, with technological advancements leading to more efficient and cost-effective sequencing methods. In future, the cost of sequencing is expected to decrease by 30%, making it more accessible to research institutions and healthcare providers. Enhanced accuracy and speed of sequencing technologies are driving increased adoption, facilitating deeper insights into the microbiome's role in health and disease, and propelling market growth.

Market Challenges

  • High Costs of Sequencing Services:Despite technological advancements, the high costs associated with microbiome sequencing services remain a significant barrier. In future, the average cost of comprehensive microbiome analysis in Thailand is estimated at THB 55,000 per sample. This price point limits accessibility for smaller healthcare providers and research institutions, hindering widespread adoption and utilization of sequencing services, which could otherwise enhance patient care and research outcomes.
  • Limited Awareness Among Healthcare Providers:A considerable challenge facing the microbiome sequencing market in Thailand is the limited awareness and understanding of its benefits among healthcare providers. A future survey indicates that only 45% of healthcare professionals are familiar with microbiome sequencing applications. This knowledge gap restricts the integration of microbiome data into clinical practice, slowing the adoption of innovative treatment strategies and limiting market growth potential.

Thailand Microbiome Sequencing Outsourcing Services Market Future Outlook

The future of the microbiome sequencing outsourcing services market in Thailand appears promising, driven by increasing investments in healthcare innovation and research. As the government allocates more funding towards microbiome studies, collaboration between academic institutions and private companies is expected to flourish. Additionally, the integration of artificial intelligence in data analysis will enhance the efficiency and accuracy of sequencing, paving the way for novel therapeutic approaches and improved patient outcomes in the coming years.

Market Opportunities

  • Expansion of Research Collaborations:There is a growing opportunity for research collaborations between universities and biotech firms in Thailand. By pooling resources and expertise, these partnerships can accelerate microbiome research, leading to innovative applications in healthcare and agriculture, ultimately enhancing the market for sequencing services.
  • Development of New Diagnostic Tools:The increasing focus on gut health presents an opportunity for the development of new diagnostic tools based on microbiome analysis. As consumer interest in personalized health solutions rises, companies can leverage microbiome data to create innovative products, driving demand for sequencing services and expanding market reach.

Scope of the Report

SegmentSub-Segments
By Type

Whole Genome Sequencing

Targeted Sequencing

Metagenomic Sequencing

RNA Sequencing

Others

By End-User

Academic Research Institutions

Pharmaceutical Companies

Clinical Laboratories

Biotechnology Firms

Others

By Application

Disease Diagnosis

Drug Development

Nutritional Analysis

Environmental Monitoring

Others

By Sample Type

Stool Samples

Blood Samples

Saliva Samples

Tissue Samples

Others

By Region

Central Thailand

Northern Thailand

Northeastern Thailand

Southern Thailand

By Technology

Illumina Sequencing

Ion Torrent Sequencing

PacBio Sequencing

Nanopore Sequencing

Others

By Research Focus

Microbial Ecology

Human Health

Agricultural Microbiomes

Industrial Applications

Others

Key Target Audience

Investors and Venture Capitalist Firms

Government and Regulatory Bodies (e.g., Ministry of Public Health, National Science and Technology Development Agency)

Biotechnology and Pharmaceutical Companies

Healthcare Providers and Hospitals

Clinical Research Organizations

Food and Beverage Manufacturers

Cosmetic and Personal Care Companies

Health and Wellness Product Developers

Players Mentioned in the Report:

BGI Group

Illumina, Inc.

Thermo Fisher Scientific

Novogene Co., Ltd.

Macrogen, Inc.

QIAGEN N.V.

Genomatix Software GmbH

Zymo Research Corp.

Oxford Nanopore Technologies

Roche Sequencing Solutions

Agilent Technologies

Bio-Rad Laboratories

PerkinElmer, Inc.

Ginkgo BioWorks

Table of Contents

Market Assessment Phase

1. Executive Summary and Approach


2. Thailand Microbiome Sequencing Outsourcing Services Market Overview

2.1 Key Insights and Strategic Recommendations

2.2 Thailand Microbiome Sequencing Outsourcing Services Market Overview

2.3 Definition and Scope

2.4 Evolution of Market Ecosystem

2.5 Timeline of Key Regulatory Milestones

2.6 Value Chain & Stakeholder Mapping

2.7 Business Cycle Analysis

2.8 Policy & Incentive Landscape


3. Thailand Microbiome Sequencing Outsourcing Services Market Analysis

3.1 Growth Drivers

3.1.1 Increasing demand for personalized medicine
3.1.2 Rising prevalence of chronic diseases
3.1.3 Advancements in sequencing technologies
3.1.4 Growing investment in microbiome research

3.2 Market Challenges

3.2.1 High costs of sequencing services
3.2.2 Limited awareness among healthcare providers
3.2.3 Regulatory hurdles in data privacy
3.2.4 Competition from in-house sequencing capabilities

3.3 Market Opportunities

3.3.1 Expansion of research collaborations
3.3.2 Development of new diagnostic tools
3.3.3 Increasing government funding for microbiome studies
3.3.4 Rising consumer interest in gut health

3.4 Market Trends

3.4.1 Growth of microbiome-based therapeutics
3.4.2 Integration of AI in sequencing analysis
3.4.3 Shift towards decentralized testing
3.4.4 Emphasis on sustainable practices in sequencing

3.5 Government Regulation

3.5.1 Data protection laws affecting sequencing data
3.5.2 Guidelines for microbiome research funding
3.5.3 Regulations on clinical applications of microbiome data
3.5.4 Standards for laboratory practices in sequencing

4. SWOT Analysis


5. Stakeholder Analysis


6. Porter's Five Forces Analysis


7. Thailand Microbiome Sequencing Outsourcing Services Market Size, 2019-2024

7.1 By Value

7.2 By Volume

7.3 By Average Selling Price


8. Thailand Microbiome Sequencing Outsourcing Services Market Segmentation

8.1 By Type

8.1.1 Whole Genome Sequencing
8.1.2 Targeted Sequencing
8.1.3 Metagenomic Sequencing
8.1.4 RNA Sequencing
8.1.5 Others

8.2 By End-User

8.2.1 Academic Research Institutions
8.2.2 Pharmaceutical Companies
8.2.3 Clinical Laboratories
8.2.4 Biotechnology Firms
8.2.5 Others

8.3 By Application

8.3.1 Disease Diagnosis
8.3.2 Drug Development
8.3.3 Nutritional Analysis
8.3.4 Environmental Monitoring
8.3.5 Others

8.4 By Sample Type

8.4.1 Stool Samples
8.4.2 Blood Samples
8.4.3 Saliva Samples
8.4.4 Tissue Samples
8.4.5 Others

8.5 By Region

8.5.1 Central Thailand
8.5.2 Northern Thailand
8.5.3 Northeastern Thailand
8.5.4 Southern Thailand

8.6 By Technology

8.6.1 Illumina Sequencing
8.6.2 Ion Torrent Sequencing
8.6.3 PacBio Sequencing
8.6.4 Nanopore Sequencing
8.6.5 Others

8.7 By Research Focus

8.7.1 Microbial Ecology
8.7.2 Human Health
8.7.3 Agricultural Microbiomes
8.7.4 Industrial Applications
8.7.5 Others

9. Thailand Microbiome Sequencing Outsourcing Services Market Competitive Analysis

9.1 Market Share of Key Players

9.2 Cross Comparison of Key Players

9.2.1 Company Name
9.2.2 Group Size (Large, Medium, or Small as per industry convention)
9.2.3 Revenue Growth Rate
9.2.4 Customer Acquisition Cost
9.2.5 Market Penetration Rate
9.2.6 Customer Retention Rate
9.2.7 Pricing Strategy
9.2.8 Average Turnaround Time
9.2.9 Service Diversification Index
9.2.10 Client Satisfaction Score

9.3 SWOT Analysis of Top Players

9.4 Pricing Analysis

9.5 Detailed Profile of Major Companies

9.5.1 BGI Group
9.5.2 Illumina, Inc.
9.5.3 Thermo Fisher Scientific
9.5.4 Novogene Co., Ltd.
9.5.5 Macrogen, Inc.
9.5.6 QIAGEN N.V.
9.5.7 Genomatix Software GmbH
9.5.8 Zymo Research Corp.
9.5.9 Oxford Nanopore Technologies
9.5.10 Roche Sequencing Solutions
9.5.11 Agilent Technologies
9.5.12 Bio-Rad Laboratories
9.5.13 PerkinElmer, Inc.
9.5.14 Ginkgo BioWorks
9.5.15 Genomatix Software GmbH

10. Thailand Microbiome Sequencing Outsourcing Services Market End-User Analysis

10.1 Procurement Behavior of Key Ministries

10.1.1 Budget Allocation Trends
10.1.2 Decision-Making Processes
10.1.3 Preferred Service Providers
10.1.4 Evaluation Criteria for Services

10.2 Corporate Spend on Infrastructure & Energy

10.2.1 Investment Trends in Microbiome Research
10.2.2 Budgeting for Outsourced Services
10.2.3 Long-term Contracts vs. Short-term Engagements
10.2.4 Impact of Economic Conditions on Spending

10.3 Pain Point Analysis by End-User Category

10.3.1 Challenges in Data Management
10.3.2 Limitations in Current Technologies
10.3.3 Need for Custom Solutions
10.3.4 Regulatory Compliance Issues

10.4 User Readiness for Adoption

10.4.1 Awareness of Microbiome Benefits
10.4.2 Training and Support Needs
10.4.3 Infrastructure Readiness
10.4.4 Willingness to Invest in New Technologies

10.5 Post-Deployment ROI and Use Case Expansion

10.5.1 Metrics for Success Measurement
10.5.2 Case Studies of Successful Implementations
10.5.3 Future Use Cases for Microbiome Data
10.5.4 Feedback Mechanisms for Continuous Improvement

11. Thailand Microbiome Sequencing Outsourcing Services Market Future Size, 2025-2030

11.1 By Value

11.2 By Volume

11.3 By Average Selling Price


Go-To-Market Strategy Phase

1. Whitespace Analysis + Business Model Canvas

1.1 Market Gaps Identification

1.2 Business Model Framework


2. Marketing and Positioning Recommendations

2.1 Branding Strategies

2.2 Product USPs


3. Distribution Plan

3.1 Urban Retail vs Rural NGO Tie-ups


4. Channel & Pricing Gaps

4.1 Underserved Routes

4.2 Pricing Bands


5. Unmet Demand & Latent Needs

5.1 Category Gaps

5.2 Consumer Segments


6. Customer Relationship

6.1 Loyalty Programs

6.2 After-sales Service


7. Value Proposition

7.1 Sustainability

7.2 Integrated Supply Chains


8. Key Activities

8.1 Regulatory Compliance

8.2 Branding

8.3 Distribution Setup


9. Entry Strategy Evaluation

9.1 Domestic Market Entry Strategy

9.1.1 Product Mix
9.1.2 Pricing Band
9.1.3 Packaging

9.2 Export Entry Strategy

9.2.1 Target Countries
9.2.2 Compliance Roadmap

10. Entry Mode Assessment

10.1 JV

10.2 Greenfield

10.3 M&A

10.4 Distributor Model


11. Capital and Timeline Estimation

11.1 Capital Requirements

11.2 Timelines


12. Control vs Risk Trade-Off

12.1 Ownership vs Partnerships


13. Profitability Outlook

13.1 Breakeven Analysis

13.2 Long-term Sustainability


14. Potential Partner List

14.1 Distributors

14.2 JVs

14.3 Acquisition Targets


15. Execution Roadmap

15.1 Phased Plan for Market Entry

15.1.1 Market Setup
15.1.2 Market Entry
15.1.3 Growth Acceleration
15.1.4 Scale & Stabilize

15.2 Key Activities and Milestones

15.2.1 Milestone Planning
15.2.2 Activity Tracking

Research Methodology

ApproachModellingSample

Phase 1: Approach1

Desk Research

  • Analysis of published reports from Thai health and biotechnology organizations
  • Review of academic journals focusing on microbiome research and applications
  • Examination of industry white papers and market analysis from relevant trade associations

Primary Research

  • Interviews with key opinion leaders in microbiome research and biotechnology
  • Surveys targeting laboratory managers and directors in microbiome sequencing facilities
  • Field interviews with stakeholders in healthcare and pharmaceutical sectors utilizing microbiome data

Validation & Triangulation

  • Cross-validation of findings through multiple data sources including academic and industry reports
  • Triangulation of insights from primary interviews with secondary data trends
  • Sanity checks conducted through expert panel discussions and feedback sessions

Phase 2: Market Size Estimation1

Top-down Assessment

  • Estimation of market size based on national healthcare expenditure and biotechnology investments
  • Segmentation of the market by application areas such as clinical diagnostics and research
  • Incorporation of government initiatives promoting microbiome research and development

Bottom-up Modeling

  • Collection of data on service pricing from leading microbiome sequencing service providers
  • Volume estimates based on the number of samples processed by key laboratories
  • Cost analysis derived from operational expenses and pricing models of sequencing services

Forecasting & Scenario Analysis

  • Multi-factor regression analysis incorporating trends in healthcare spending and research funding
  • Scenario modeling based on potential regulatory changes and technological advancements
  • Development of baseline, optimistic, and pessimistic forecasts through 2030

Phase 3: CATI Sample Composition1

Scope Item/SegmentSample SizeTarget Respondent Profiles
Clinical Microbiome Applications100Clinical Researchers, Healthcare Practitioners
Pharmaceutical R&D80Pharmaceutical Scientists, R&D Managers
Academic Research Institutions70University Professors, Research Fellows
Biotechnology Firms90Business Development Managers, Product Managers
Healthcare Providers60Laboratory Directors, Pathologists

Frequently Asked Questions

What is the current value of the Thailand Microbiome Sequencing Outsourcing Services Market?

The Thailand Microbiome Sequencing Outsourcing Services Market is valued at approximately USD 140 million, reflecting significant growth driven by factors such as chronic disease prevalence, personalized medicine awareness, and advancements in sequencing technologies.

What are the key drivers of growth in the Thailand Microbiome Sequencing Market?

Which cities in Thailand are prominent in the microbiome sequencing market?

What types of sequencing services are offered in the Thailand Microbiome Market?

Why Buy From Us?

Refine Robust Result (RRR) Framework
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follow Robust, Refine and Result (RRR) methodology. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents' facts and opinions, and Result for presenting data with story.

Our Reach Is Unmatched
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Shifting the Research Paradigm
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

More Insights-Better Decisions
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Transparency and Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

Round the Clock Support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Clients Choose Us?

400000+
Reports in repository
150+
Consulting projects a year
100+
Analysts
8000+
Client Queries in 2022